BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6186298)

  • 21. Immunologic studies in schizophrenic and control subjects.
    Bergen JR; Grinspoon L; Pyle HM; Martinez JL; Pennell RB
    Biol Psychiatry; 1980 Jun; 15(3):369-79. PubMed ID: 7189673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibodies in epilepsy and seizure-associated disorders.
    McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
    Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmunity and schizophrenia: an epiphenomenon or an etiology?
    Amital H; Shoenfeld Y
    Isr J Med Sci; 1993 Sep; 29(9):593-7. PubMed ID: 8225948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observation on anti-brain antibody in serum of 110 epileptics.
    Xie XK; Tang LO
    Chin Med J (Engl); 1990 Jan; 103(1):71-5. PubMed ID: 2112448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features of patients with the paranoid form of schizophrenia with brain antibodies and brain antigens in their serum and cerebrospinal fluid].
    Savina IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(1):92-7. PubMed ID: 5771498
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibodies to brain tissue in sera of schizophrenic patients--preliminary findings.
    Henneberg AE; Ruffert S; Henneberg HJ; Kornhuber HH
    Eur Arch Psychiatry Clin Neurosci; 1993; 242(5):314-7. PubMed ID: 8499502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunopathology in craniocerebral trauma].
    Ermekov ZhM
    Zh Vopr Neirokhir Im N N Burdenko; 1997; (2):23-5. PubMed ID: 9235830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tubulin antibodies in autoimmune thyroid disorders.
    Rousset B; Bernier-Valentin F; Poncet C; Orgiazzi J; Madec AM; Monier JC; Mornex R
    Clin Exp Immunol; 1983 May; 52(2):325-32. PubMed ID: 6688044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinico-immunological characteristics of schizophrenia patients based on neurocytotoxic test data].
    Semenov SF; Vilkov GA; Siziakina LP; Kogan RD; Mogilina NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1069-73. PubMed ID: 6332442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychoneuroimmunology: an autoimmune pathogenesis for schizophrenia.
    Heath RG
    Psychiatr Med; 1990; 8(1):95-110. PubMed ID: 2198615
    [No Abstract]   [Full Text] [Related]  

  • 31. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.
    Dale RC; Church AJ; Surtees RA; Lees AJ; Adcock JE; Harding B; Neville BG; Giovannoni G
    Brain; 2004 Jan; 127(Pt 1):21-33. PubMed ID: 14570817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-brain antibodies in serum and cerebrospinal fluid following cranio-cerebral trauma].
    Detlav IE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):344-8. PubMed ID: 1266503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of antisyphilitic treatment on the frequency of detection of antibrain autoantibodies in the blood and cerebrospinal fluid of patients with syphilis].
    Tumasheva NI; Garmatiuk GK
    Vestn Dermatol Venerol; 1968; 42(9):43-7. PubMed ID: 5742372
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera.
    Borda T; Gomez R; Berría MI; Sterin-Borda L
    Glia; 2004 Jan; 45(2):144-54. PubMed ID: 14730708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinico-immunologic study of epileptic children and adolescents and their relatives].
    Popova NN; Amadian MG; Umanskaia RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(8):1194-7. PubMed ID: 1217412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ultrastructural and biochemical evidence of brain damage by the serum IgG fraction of the blood of schizophrenics].
    Vilkov GA; Bardakhch'ian EA; Stepanenko EM; Siletskiĭ OIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):767-70. PubMed ID: 6547798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cerebral auto-antigens in the serum of schizophrenic patients].
    Popova NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Apr; 76(4):543-9. PubMed ID: 936849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?
    Zorrilla EP; Cannon TD; Gur RE; Kessler J
    Biol Psychiatry; 1996 Nov; 40(9):825-33. PubMed ID: 8896768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.